Influences of hyaluronic acid on the anticandidal activities of lysozyme and the peroxidase system

Oral Diseases

Volumn 17, Issue 6, 2011, Pages 577-583

  Kang, J H ^a   Kim, Y Y ^a   Chang, J Y ^a   Kho, H S ^a  

^a Seoul National University   (South Korea)

Author keywords

Anticandidal activity; Hyaluronic acid; Lysozyme; Peroxidase

Indexed keywords

HYALURONIC ACID; LYSOZYME; PEROXIDASE;

ANTICANDIDAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; FUNGICIDAL ACTIVITY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CATTLE; COLONY COUNT, MICROBIAL; ENZYME INHIBITORS; HYALURONIC ACID; LACTOPEROXIDASE; MURAMIDASE; MYCOLOGY;

EID: 79960700891     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01807.x     Document Type: Article

References (37)

1. Almond A (2007). Hyaluronan. Cell Mol Life Sci 64: 1591-1596.
2. Avila JL, Convit J (1975). Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem J 152: 57-64.
3. Balmer RT, Hirsch SR (1978). The non-Newtonian behaviour of human saliva. AIChE symposium series on biorheology No 181 74: 125-129.
4. Bennick A, Cannon M (1978). Quantitative study of the interaction of salivary acidic proline-rich proteins with hydroxyapatite. Caries Res 12: 159-169.
5. Chen WY, Abatangelo G (1999). Functions of hyaluronan in wound repair. Wound Repair Regen 7: 79-89.
6. Fam H, Bryant JT, Kontopoulou M (2007). Rheological properties of synovial fluids. Biorheology 44: 59-74.
7. Green SP, Baker MS, Lowther DA (1990). Depolymerization of synovial fluid hyaluronic acid (HA) by the complete myeloperoxidase (MPO) system may involve the formation of a HA-MPO ionic complex. J Rheumatol 17: 1670-1675.
8. Higuchi Y, Ansai T, Awano S et al (2009). Salivary levels of hyaluronic acid in female patients with dry mouth compared with age-matched controls: a pilot study. Biomed Res 30: 63-68.
9. Jentsch H, Pomowski R, Kundt G, Göcke R (2003). Treatment of gingivitis with hyaluronan. J Clin Periodontol 30: 159-164.
10. Last KS, Embery G (1987). Hyaluronic acid and hyaluronidase activity in gingival exudate from sites of acute ulcerative gingivitis in man. Arch Oral Biol 32: 811-815.
11. Lee JY, Kim YY, Chang JY, Park MS, Kho HS (2010). The effects of peroxidase on the enzymatic and candidacidal activities of lysozyme. Arch Oral Biol 55: 607-612.
12. Lehrer RI (1969). Antifungal effects of peroxidase systems. J Bacteriol 99: 361-365.
13. 2 system. Oral Microbiol Immunol 7: 315-320.
14. Lenander-Lumikari M, Mansson-Rahemtulla B, Rahemtulla F (1992). Lysozyme enhances the inhibitory effects of the peroxidase system on glucose metabolism of Streptococcus mutans. J Dent Res 71: 484-490.
15. Levine MJ (1993). Development of artificial salivas. Crit Rev Oral Biol Med 4: 279-286.
16. Locci P, Marinucci L, Lilli C, Martinese D, Becchetti E (1995). Transforming growth factor beta 1 - hyaluronic acid interaction. Cell Tissue Res 281: 317-324.
17. Marquis G, Montplaisir S, Garzon S, Strykowski H, Auger P (1982). Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab Invest 46: 627-636.
18. Marquis G, Garzon S, Strykowski H, Auger P (1991). Cell walls of normal and lysozyme-damaged blastoconidia of Candida albicans: localization of surface factor 4 antigen and vicinal-glycol staining. Infect Immun 59: 1312-1318.
19. Moss JM, Van Damme MP, Murphy WH, Preston BN (1997). Dependence of salt concentration on glycosaminoglycan - lysozyme interactions in cartilage. Arch Biochem Biophys 348: 49-55.
20. O'Brien PD, Collum LM (2004). Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep 4: 314-319.
21. Park MS, Chang JY, Kang JH, Park KP, Kho HS (2010). Rheological properties of hyaluronic acid and its effects on salivary enzymes and candida. Oral Dis 16: 382-387.
22. Petit JF, Jolles P (1963). Purification and analysis of human saliva lysozyme. Nature 200: 168-169.
23. Pogrel MA, Lowe MA, Stern R (1996). Hyaluronan (hyaluronic acid) in human saliva. Arch Oral Biol 41: 667-671.
24. Pogrel MA, Low MA, Stern R (2003). Hyaluronan (hyaluronic acid) and its regulation in human saliva by hyaluronidase and its inhibitors. J Oral Sci 45: 85-91.
25. Porter SR, Scully C, Hegarty AM (2004). An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97: 28-46.
26. Regelink G, Vissink A, Reintsema H, Nauta JM (1998). Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 29: 383-388.
27. Sakai A, Akifusa S, Itano N et al (2007). Potential role of high molecular weight hyaluronan in the anti-Candida activity of human oral epithelial cells. Med Mycol 45: 73-79.
28. Steele C, Leigh J, Swoboda R, Ozenci H, Fidel PL Jr (2001). Potential role for a carbohydrate moiety in anti-Candida activity of human epithelial cells. Infect Immun 69: 7091-7099.
29. Tenovuo J (2002). Clinical applications of antimicrobial host proteins, lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 8: 23-29.
30. Tobgi RS, Samaranayake LP, MacFarlane TW (1988). In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 3: 35-39.
31. Van Damme MP, Moss JM, Murphy WH, Preston BN (1991). Binding of hyaluronan to lysozyme at various pHs and salt concentrations. Biochem Int 24: 605-613.
32. Van Damme MP, Moss JM, Murphy WH, Preston BN (1994). Binding properties of glycosaminoglycans to lysozyme - effect of salt and molecular weight. Arch Biochem Biophys 310: 16-24.
33. Vissink A, Waterman HA, 's-Gravenmade EJ, Panders AK, Vermey A (1984). Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or polyethylenoxide. J Oral Pathol 13: 22-28.
34. Weerkamp AH, Wagner K, Vissink A, 's-Gravenmade EJ (1987). Effect of the application of a mucin-based saliva substitute on the oral microflora of xerostomic patients. J Oral Pathol 16: 474-478.
35. Welk A, Meller Ch, Schubert R, Schwahn Ch, Kramer A, Below H (2009). Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test. BMC Microbiol 9: 134.
36. Wright CD, Bowie JU, Gray GR, Nelson RD (1983). Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun 42: 76-80.
37. Wu T, Samaranayake LP, Leung WK, Sullivan PA (1999). Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol 48: 721-730.